Created from work carried out by three research experts, Alvéole’s goal is to make the control of living cells the future of cell biology.
A company specialized in devices for controlling the cellular microenvironment, Alvéole presents its first device PRIMO.
Alvéole was founded in 2010 by three researchers from CNRS* in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products.
Vincent Studer (a specialist in bio-engineering), Maxime Dahan (a specialist in cell imaging), and Jean-Christophe Galas (a specialist in nanostructures) have collaborated since 2008 to develop tools for research in cell biology. In 2010, Quattrocento founded Alvéole, with their collaboration.
*Vincent Studer, the Neurosciences Interdisciplinary Institute (CNRS, University of Bordeaux).
Maxime Dahan, the Curie Physics and Chemistry Unit, (CNRS, Curie Institute, Pierre and Marie Curie University).
Jean-Christophe Galas, the Jean Perrin Laboratory, (CNRS, Pierre and Marie Curie University).
Company Details
- Employees
- 14
- Address
- 68, Bd De Port-Royal, Paris,75005,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.alveolelab.com
- Keywords
- photopatterning, control of the cell microenvironment, micropatterning, Living cells control, cell adhesion, cell migration, traction forces, cell biology, biophysics.
- HQ
- Paris
Alvéole Questions
Alvéole's website is http://www.alveolelab.com
Alvéole's LinkedIn profile is https://fr.linkedin.com/company/alv%C3%A9ole
Alvéole has
14 employees.
View email and phone details for 14
employees at Alvéole.
Alvéole's industry is
Biotechnology Research
Alvéole's top competitors are
Cherry Biotech,
4dcell,
Myriade,
Orakl Oncology,
Idylle,
Etap-Lab - Preclinical Efficacy Cro,
Optics11 Life,
Biohive,
Quattrocento,
Alvéole.
Alvéole's categories are Biotechnology Research
